Across TCGA pan-cancer cohorts, GSTA11P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of GSTA11P’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where GSTA11P RNA is repressed in tumor relative to normal tissue. In most cancer types GSTA11P is over-expressed in tumor, although a few such as STAD and KIRP show the opposite, repressed pattern.

STAD, KIRP, and LIHC are the cancer types where GSTA11P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in GSTA11P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	All	−0.034	.019	3	view →
KIRP	All	All	−0.024	.005	2	view →
LIHC	All	All	−0.026	.044	1	view →
THCA	All	All	−0.009	.023	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: GSTA11P RNA expression & survival · all GSTA11P data types